Results 11 to 20 of about 32,051 (265)
Percutaneous Paravalvular Leak Closure [PDF]
Current Treatment Options in Cardiovascular Medicine, 2011 Symptomatic paravalvular leak (PVL) complicates up to 12 % of surgical valve replacements. When patients present with congestive heart failure and/or haemolysis, reoperation for repeat valve replacement may be undertaken, but presents greater risk and lower likelihood of success than the initial operation.
Amar, Krishnaswamy +2 more
openaire +3 more sources
Percutaneous left atrial appendage closure [PDF]
Vnitřní lékařství, 2020 Stroke is one of the most severe complications of atrial fibrillation. Oral anticoagulation is the first choice therapy in prevention of cardiac embolic events. Particularly in patients with the history of serious bleeding, oral anticoagulation may be contraindicated.
Marek, Hozman, Pavel, Osmančík
openaire +2 more sources
Hazards of percutaneous PFO closure [PDF]
European Journal of Echocardiography, 2005 Please see the article by Christen et al. (doi: 10.1016/j.euje.2005.08.002 ) to which this editorial pertains. In 2004, an estimated 2000–3000 patients underwent percutaneous closure of a patent foramen ovale (PFO). Given the range of potential indications (such as prevention of cryptogenic stroke, decompression illness in divers, platypnea ...
Markus, Schwerzmann, Omid, Salehian
openaire +2 more sources
How to Size ASDs for Percutaneous Closure [PDF]
Pediatric Cardiology, 2017 Percutaneous closure is the treatment of choice for secundum-type atrial septal defects (ASD). Balloon sizing (BS) has been the method of choice for deciding on device size. Improved 2D- and 3D-transesophageal echocardiographic (TEE) imaging challenged the necessity of BS.
Isabelle Boon +9 more
openaire +3 more sources
Percutaneous closure of an acquired Gerbode defect [PDF]
European Heart Journal – Cardiovascular Imaging, 2016 An 89-year-old woman with history of bioprosthetic aortic valve replacement presented with worsening exertional dyspnoea. A transthoracic echocardiogram demonstrated the presence of a fistula between the left ventricle (LV) and right atrium (RA), consistent with an acquired Gerbode defect.
Amita, Singh +4 more
openaire +2 more sources
The Pan African Medical Journal, 2021 Percutaneous transcatheter closure has gained acceptance for Patent ductus Arteriosus (PDA) management ever since its introduction, including management for small residual left to right shunt following surgical ligation.
Alexander Edo Tondas +5 more
doaj +1 more source
The Scientific World Journal, 2012 Background. B-type natriuretic peptide has been shown to be a very sensitive and specific marker of heart failure. In this study, we aimed to investigate the effect of percutaneous closure of ventricular septal defects with Amplatzer septal occluders on ...
Yuksel Kaya +11 more
doaj +1 more source
Case Reports in Anesthesiology, 2021 Extremely low birth weight (ELBW) infants weighing less than 1 kilogram are at a high-risk for delayed patent ductus arteriosus (PDA) closure. Percutaneous PDA closure offers a less invasive approach when compared with surgical PDA closure, which may ...
Tiffany M. Pouldar +4 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 IntroductionSince the first successful percutaneous closure under transesophageal echocardiographic (TEE) guidance, many centers explored transcatheter procedures without fluoroscopy.
Sisca Natalia Siagian +13 more
doaj +1 more source
Percutaneous closure of giant left appendages: [PDF]
European Heart Journal – Cardiovascular Imaging, 2015 We present two patients in chronic non-valvular atrial fibrillation with absolute contraindication to anticoagulation who were initially rejected for percutaneous closure of the left atrial appendage (LAA) due to the large size of it. Two devices have made the percutaneous closure of both appendages successful at …
Luisa, Salido-Tahoces +4 more
openaire +2 more sources